ClinicalTrials.gg
RecruitingNCT05405452Updated Aug 18, 2023

Vibratory Anesthesia in Trigger Finger Injections

A Phase 4 interventional study of Vibration Anesthesia Device by Blaine Labs and Gebauers Ethyl Chloride 100% Topical Spray in Trigger Finger, Pain and Anesthesia, Local, sponsored by University of Arizona. Recruiting at 2 sites in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-08-18.

Sponsored by University of Arizona · Phase 4, Interventional, and Other

From the registry’s dates

  • Primary completion was expected by Aug 2025, 1 year 3 months ago, but the record still lists the study as recruiting.
  • Started Aug 2023; still recruiting 3 years 2 months later.
Phase
Phase 4
Study type
Interventional
Enrollment
1,000
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to compare the effectiveness of the use of no topical anesthesia, topical coolant, and the use of vibration in the reduction of pain during trigger finger injections. This will be done by randomizing patients who are diagnosed with trigger finger, warrant and choose to continue with a steroid injection into each of the respective anesthetic (or lack thereof) methods described. After conducting this and gathering data on the subjects pain felt, we will compare the analgesia from each of the anesthetic methods.

02

Conditions studied

  • Trigger Finger
  • Pain
  • Anesthesia, Local
03

In context

Trigger Finger Disorder

93 studies on the registry are indexed under Trigger Finger Disorder; 22 are open to participants now.

This study's planned enrollment of 1,000 is above the median of 66 across 75 interventional studies indexed under Trigger Finger Disorder.

Browse Trigger Finger Disorder studies →

Lead sponsor

University of Arizona is the lead sponsor of 476 studies on the registry; 88 are open to participants now.

Of its 51 completed or terminated interventional studies of FDA-regulated products, 30 (59%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy Adult
  • Diagnosed with trigger finger
  • Warrants a trigger finger injection

Exclusion criteria

Exclusion Criteria:

  • Subjects with known decreased light touch sensation in the territory of the trigger finger injection.
  • Not diagnosed with trigger finger or does not warrant a trigger finger injection per the typical treatment algorithm adopted by the attending physician.
05

Study design

Phase
Phase 4
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
1,000 participants (estimated)

Study arms

  • No intervention
    No topical anesthesia

    No topical anesthesia will be given during the trigger finger injection.

  • Experimental
    Topical coolant

    The subject will have 5 seconds of sterile ethyl chloride sprayed at the site of the trigger finger injections just prior to the administration of the injection.

    Drug: Gebauers Ethyl Chloride 100% Topical Spray

  • Experimental
    Vibration

    The subject will have a vibration device placed just proximal to the site of the trigger finger injection concurrent with the administration of the injection.

    Device: Vibration Anesthesia Device by Blaine Labs

Interventions

06

What researchers measure

Primary outcomes

  1. Pain Felt

    Visual Analog Pain Scale Rating (Hayes and Patterson 1921) Scale Title: Pain scale Maximum Value: 10 - The worst pain Minimum value: 0 - No pain \*A lower number indicates a better outcome (less pain felt).

    Time frame: Immediately after the trigger finger injection is completed

07

Study locations

2 of 2 sites recruiting
  • Banner UMC North Hills Clinic
    Tucson, Arizona 85704, United States
    Recruiting
    • · Contact520-694-8888
  • Banner University Alvernon Clinic
    Tucson, Arizona 85711, United States
    Recruiting
    • · Contact520-694-8888
08

References and documents

Publications

  • Blazar, P. and R. Aggarwal, Trigger finger (stenosing flexor tenosynovitis). 2018.
  • Sampson SP, Badalamente MA, Hurst LC, Seidman J. Pathobiology of the human A1 pulley in trigger finger. J Hand Surg Am. 1991 Jul;16(4):714-21. doi: 10.1016/0363-5023(91)90200-u. PubMed 1880372 ↗
  • Sbernardori MC, Bandiera P. Histopathology of the A1 pulley in adult trigger fingers. J Hand Surg Eur Vol. 2007 Oct;32(5):556-9. doi: 10.1016/J.JHSE.2007.06.002. Epub 2007 Aug 7. PubMed 17950222 ↗
  • Makkouk AH, Oetgen ME, Swigart CR, Dodds SD. Trigger finger: etiology, evaluation, and treatment. Curr Rev Musculoskelet Med. 2008 Jun;1(2):92-6. doi: 10.1007/s12178-007-9012-1. PubMed 19468879 ↗
  • Petchprapa CN, Vaswani D. MRI of the Fingers: An Update. AJR Am J Roentgenol. 2019 Sep;213(3):534-548. doi: 10.2214/AJR.19.21217. Epub 2019 Jul 3. PubMed 31268729 ↗
  • Lunsford D, Valdes K, Hengy S. Conservative management of trigger finger: A systematic review. J Hand Ther. 2019 Apr-Jun;32(2):212-221. doi: 10.1016/j.jht.2017.10.016. Epub 2017 Dec 28. PubMed 29290504 ↗
  • Dala-Ali BM, Nakhdjevani A, Lloyd MA, Schreuder FB. The efficacy of steroid injection in the treatment of trigger finger. Clin Orthop Surg. 2012 Dec;4(4):263-8. doi: 10.4055/cios.2012.4.4.263. Epub 2012 Nov 16. PubMed 23205235 ↗
  • Wojahn RD, Foeger NC, Gelberman RH, Calfee RP. Long-term outcomes following a single corticosteroid injection for trigger finger. J Bone Joint Surg Am. 2014 Nov 19;96(22):1849-54. doi: 10.2106/JBJS.N.00004. PubMed 25410501 ↗
  • Franko OI, Stern PJ. Use and Effectiveness of Ethyl Chloride for Hand Injections. J Hand Surg Am. 2017 Mar;42(3):175-181.e1. doi: 10.1016/j.jhsa.2016.12.013. PubMed 28259274 ↗
  • Moayedi M, Davis KD. Theories of pain: from specificity to gate control. J Neurophysiol. 2013 Jan;109(1):5-12. doi: 10.1152/jn.00457.2012. Epub 2012 Oct 3. PubMed 23034364 ↗
  • Sharma P, Czyz CN, Wulc AE. Investigating the efficacy of vibration anesthesia to reduce pain from cosmetic botulinum toxin injections. Aesthet Surg J. 2011 Nov;31(8):966-71. doi: 10.1177/1090820X11422809. Epub 2011 Oct 14. PubMed 22001341 ↗
  • Nanitsos E, Vartuli R, Forte A, Dennison PJ, Peck CC. The effect of vibration on pain during local anaesthesia injections. Aust Dent J. 2009 Jun;54(2):94-100. doi: 10.1111/j.1834-7819.2009.01100.x. PubMed 19473149 ↗
  • Nasehi A, Bhardwaj S, Kamath AT, Gadicherla S, Pentapati KC. Clinical pain evaluation with intraoral vibration device during local anesthetic injections. J Clin Exp Dent. 2015 Feb 1;7(1):e23-7. doi: 10.4317/jced.51643. eCollection 2015 Feb. PubMed 25810837 ↗
  • Park KY, Lee Y, Hong JY, Chung WS, Kim MN, Kim BJ. Vibration Anesthesia for Pain Reduction During Intralesional Steroid Injection for Keloid Treatment. Dermatol Surg. 2017 May;43(5):724-727. doi: 10.1097/DSS.0000000000001040. PubMed 28244902 ↗
  • Smith KC, Comite SL, Balasubramanian S, Carver A, Liu JF. Vibration anesthesia: a noninvasive method of reducing discomfort prior to dermatologic procedures. Dermatol Online J. 2004 Oct 15;10(2):1. PubMed 15530291 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 18, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05405452
Responsible party
Tolga Turker (Associate Professor, University of Arizona) — Principal investigator
First posted
Jun 6, 2022
Start date
Aug 14, 2023
Primary completion
Aug 1, 2025 (estimated)
Completion
Aug 1, 2025 (estimated)
Last update
Aug 18, 2023

Study contacts

Joey F Ghotmi, BS
Contact
joeyghotmi@email.arizona.edu
5202486350
Tolga Turker, MD
Contact
tolgaturker@email.arizona.edu
(520) 626-4024
Tolga Turker, MD
principal investigator · Associate Professor

Oversight

Data monitoring committee
No
FDA-regulated drug
Yes
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Ethyl Chloride

Start the discussion